HSK3486
HSK3486-106
Phase 1 small_molecule completed
Quick answer
HSK3486 for Chronic Renal Impairment is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Chronic Renal Impairment
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed